Tenax Therapeutics (TENX) Gross Margin: 2010-2016
Historic Gross Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to 100.00%.
- Tenax Therapeutics' Gross Margin was N/A to 100.00% in Q4 2016 from the same period last year, while for Dec 2016 it was 11.17%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2015.
- In the past 5 years, Tenax Therapeutics' Gross Margin registered a high of 100.00% during Q2 2015, and its lowest value of 0.60% during Q1 2013.
- In the last 2 years, Tenax Therapeutics' Gross Margin had a median value of 100.00% in 2016 and averaged 100.00%.
- As far as peak fluctuations go, Tenax Therapeutics' Gross Margin crashed by 9,854bps in 2012, and later soared by 706bps in 2013.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Gross Margin stood at 1.06% in 2012, then spiked by 706bps to 12.62% in 2013, then reached 100.00% in 2015, then reached 100.00% in 2016.
- Its last three reported values are 100.00% in Q4 2016, 100.00% for Q2 2015, and 12.62% during Q2 2013.